TY  - JOUR 
AU  - Alonso Vence, Natalia
PY  - 2013
SN  - 0008-543X
UR  - http://hdl.handle.net/20.500.11940/4015
LA  - eng
TI  - Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status final results of a phase 2 study (Burkimab)
DO  - 10.1002/cncr.27918
T2  - CANCER
M2  - 1660
VL  - 119
ER  -